Cite
HARVARD Citation
Lightner, A. et al. (n.d.). P428 A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory Crohn's colitis: A preliminary analysis. Journal of Crohn's and colitis. pp. i412-i413. [Online].